US6701002056
US6701002056
Novo Nordisk A/S
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 309.064.000.000 | 290.403.000.000 | 6.4% |
| Cost of Revenue | 58.788.000.000 | 44.522.000.000 | 32.0% |
| Gross Profit | 250.276.000.000 | 245.881.000.000 | 1.8% |
| 122.618.000.000 | 117.542.000.000 | 4.3% | |
| Operating Income | 127.658.000.000 | 128.339.000.000 | 0.5% |
| Pretax Income | 130.540.000.000 | 127.191.000.000 | 2.6% |
| Net Income Common Stockholders | 102.434.000.000 | 100.988.000.000 | 1.4% |
| -- | -- | -- | |
| -- | -- | -- |